Gypenoside XIII

Gypenoside XIII

• CAS Number: 80325-22-0
• UNSPSC Description: Gypenoside XIII is belonging to the gypenosides. Gypenosides, extracted from Gynostemma pentaphyllum, have various pharmacological properties and protect against cardiovascular diseases, especially atherosclerosis[1].
• Target Antigen: Others
• Type: Natural Products
• Related Pathways: Others
• Applications: Neuroscience-Neuromodulation
• Field of Research: Cardiovascular Disease
• Assay Protocol: https://www.medchemexpress.com/gypenoside-xiii.html
• Purity: 99.13
• Solubility: Ethanol : 50 mg/mL (ultrasonic)
• Smiles: C[C@]12[C@@](C[C@@H](O)[C@@]3([H])[C@]2(CC[C@]3([H])[C@@](CC/C=C(C)/C)(C)O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO[C@H]5[C@@H]([C@H]([C@H](O)CO5)O)O)C)([H])[C@@]6([C@@](C(C)([C@@H](O)CC6)C)([H])CC1)C
• Molecular Weight: 754.99
• References & Citations: [1]Yang K, et al. Gypenoside XVII Prevents Atherosclerosis by Attenuating Endothelial Apoptosis and Oxidative Stress: Insight into the ERα-Mediated PI3K/Akt Pathway. Int J Mol Sci. 2017 Feb 9;18(2).
• Shipping Conditions: Room Temperature
• Storage Conditions: 4°C (Powder, protect from light)
• Clinical Information: No Development Reported